Liminal BioSciences Inc. EBITDA Margin 2017-2023 | LMNL
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Liminal BioSciences Inc. (LMNL) over the last 10 years. The current EBITDA margin for Liminal BioSciences Inc. as of June 30, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-06-30 | $0.00B | $-0.02B | inf% |
| 2023-03-31 | $0.00B | $-0.02B | inf% |
| 2022-09-30 | $0.00B | $-0.02B | inf% |
| 2022-06-30 | $0.00B | $-0.03B | inf% |
| 2021-12-31 | $0.00B | $-0.04B | inf% |
| 2021-09-30 | $0.00B | $-0.05B | -4700.00% |
| 2021-06-30 | $0.00B | $-0.05B | -5000.00% |
| 2021-03-31 | $0.00B | $-0.06B | -5800.00% |
| 2020-12-31 | $0.00B | $-0.06B | -3200.00% |
| 2020-09-30 | $-0.01B | $-0.07B | 591.67% |
| 2020-06-30 | $-0.01B | $-0.08B | 950.00% |
| 2020-03-31 | $-0.00B | $-0.09B | 8500.00% |
| 2019-12-31 | $0.00B | $-0.08B | -2025.00% |
| 2019-09-30 | $0.03B | $-0.08B | -324.00% |
| 2019-06-30 | $0.03B | $-0.08B | -273.33% |
| 2019-03-31 | $0.04B | $-0.08B | -194.87% |
| 2018-12-31 | $0.04B | $-0.08B | -233.33% |
| 2018-09-30 | $0.03B | $-0.09B | -269.70% |
| 2018-06-30 | $0.04B | $-0.08B | -176.74% |
| 2018-03-31 | $0.03B | $-0.08B | -260.00% |
| 2017-12-31 | $0.03B | $-0.08B | -245.16% |
| 2017-09-30 | $0.03B | $-0.08B | -268.97% |
| 2017-06-30 | $0.01B | $-0.09B | -707.69% |
| 2017-03-31 | $0.01B | $-0.09B | -669.23% |
| 2016-12-31 | $0.01B | $-0.08B | -600.00% |
